63 -4 (32/2) 2020 — Abdurazakova D.S., Niyozova Y.M. — SUBCLINICAL HYPOTHYROIDISM AMONG FEMALE RESIDENTS IN BUZ DISTRICT OF ANDIJAN REGION

SUBCLINICAL HYPOTHYROIDISM AMONG FEMALE RESIDENTS IN BUZ DISTRICT OF ANDIJAN REGION

Abdurazakova D.S. -Andijan State Medical Institute

Niyozova Y.M. -Andijan State Medical Institute

Sakhatalieva R.R. -Andijan State Medical Institute

Mirzaahmedova I.Z. -Andijan State Medical Institute

Yuldasheva G.T. -Andijan State Medical Institute

Resume

Subclinical hypothyroidism is the most widely spread thyroid dysfunction with normal serum levels of free thyroxine (FT4) and elevated serum thyrotropin (TSH) levels. The work was initiated to study prevalence of subclinical hypothyroidism among women aged from 18 to 65 residing in Buz distract of Andijan region, Republic of Uzbekistan. It turned to be 11 % confidently increasing to 28% when TSH upper limit was reduced. Regardless of TSH upper limit subclinical hypothyroidism freduency is higher among women over 40-45 years of age than among those under 30.

Key words: thyroid stimulating hormone, free thyroxine, prevalence, subclinical hypothyroidism, hypothyroidism

First page

271

Last page

274

For citation: Abdurazakova D.S., Niyozova Y.M., Sakhatalieva R.R., Mirzaahmedova I.Z., Yuldasheva G.T.,  Subclinical hypothyroidism among female residents in buz district of andijan region//New Day in Medicine 4(32)2020 271-274 https://cutt.ly/ozwibua

List of References

1. Абдуразакова Д.С., Исмаилов С.И., ” Субклинический гипо­тиреоз диагностика и лечение ” методические рекомендации 2018 – Андижан.
2. Гаспарян Э. Г., Осташко Г. А., Гаспарян А. А., Дымнова С. Е. Особенности лечения гипотиреоза у лиц пожилого возраста / /Лечащий врач. – 2012. – №11. -С.25-29.
3. Демидова Т.Ю., Галиева О.Р. К вопросу лечения субклини­ческого гипотиреоза у больных ожирением //Клиническая и экспериментальная тиреоидология. – 2008. – Т.4, №1. – С.48-52.
4. Исмаилов С.И, Абдуразакова Д.С, ” Субклинический гипоти­реоз” методическое пособие. 2016.- Ташкент
5. Baloch Z., Carayon P., Conte-Devolx B. et al., Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease //Thyroid. – 2003. – Vol.13. – P.3-126.
6. Brabant G., Peck-Peccoz P., Jarsab B., Laurberg P., Wiersinga W. Is there a need to redefine the upper normal limit of TSH? // Eur J Endocrinol. – 2006.- Vol.154.- P.633-637.
7. Canaris G., Manowitz N., Mayor G., Ridgway E. The Colorado thyroid disease prevalence study//Arch Intern Med. – 2000.- Vol.160.- P.526-534.
8. Cooper D. Subclinical hypothyroidism //N Engl J Med. – 2001.- Vol.345(4).- P.260-265.
9. Fatourechi V., Klee G., Grebe S. et al. Effects of reducing the upper limit of normal TSH values //JAMA. – 2003. – Vol.290. – P. 3195-3196.
10. Hollowell J., Staehling N., Flanders W. et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988­1994): National Health and Nutrition Examination Survey (NHANES III) //J. Clin. Endocrinol. Metab. – 2002. – Vol. 87. – P.489-499.
11. Mahato R., Nepal A., Gelal B., Poudel B., Yadav B., Lamsal M. Spectrum of thyroid dysfunction in patients visiting Kantipur Hospital, Kathmandu, Nepal //Mymensingh Med J. – 2013.- Vol.22(1).- P.164-169.
12. Nakajima Y., Yamada M. Subclinical thyroid disease //Nihon Rinsho. – 2012.- Vol.70(11).- P.1865-1871.
13. Surks M., Ortiz E., Daniels G., Sawin C., Col N., Cobin R. et al. Subclinical thyroid disease: scientihc review and guidelines for diagnosis and management //JAMA. – 2004.- Vol.291.- P.228­238.
14. Surks M., Hollowell J. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism//J Clin Endocrinol Metab. – 2007.- Vol.92(12).- P.4575-4582.
15. Unnikrishnan A., Kalra S., Sahay R., Bantwal G., John M., Tewari N. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India//Indian J Endocrinol Metab. – 2013.- Vol.17(4).- P.647-652.
16. Vanderpump M., Tunbridge W. Epidemiology and prevention of clinical and subclinical hypothyroidism //Thyroid. – 2002. – Vol.12. -P.839-847.
17. Wartofsky L., Dickey R. Controversy in clinical endocrinology: the evidence for a narrower thyrotropin reference range is compelling //J Clin Endocrinol Metab. – 2005.- Vol.90.- P.5483­5488.
18. Yadav R., Magar N., Poudel B., Yadav N., Yadav B. A prevalence of thyroid disorder in Western part of Nepal //J Trace Elem Med Biol. – 2013.- Vol.27(2).- P.122-125

63-271-274-4-32-2020-тиббиёт-25-12-2020-—-копия